US Stock MarketDetailed Quotes

Viking Therapeutics (VKTX)

Watchlist
  • 30.000
  • -1.180-3.78%
Close May 1 15:59 ET
  • 30.079
  • +0.079+0.26%
Post 20:01 ET
3.48BMarket Cap-7.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viking Therapeutics (VKTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
195.89%164.13M
160.63%393.34M
256.28%164.74M
169.62%98.56M
118.99%74.57M
62.79%55.47M
49.68%150.92M
57.89%46.24M
34.08%36.56M
43.45%34.05M
Selling and administrative expenses
-0.73%13.98M
-1.81%48.39M
-26.04%11.28M
-37.49%8.61M
40.21%14.42M
41.20%14.08M
33.11%49.28M
73.64%15.25M
54.97%13.77M
4.70%10.29M
-General and administrative expense
-0.73%13.98M
-1.81%48.39M
-26.04%11.28M
-37.49%8.61M
40.21%14.42M
41.20%14.08M
33.11%49.28M
73.64%15.25M
54.97%13.77M
4.70%10.29M
Research and development costs
262.76%150.15M
239.38%344.96M
395.24%153.46M
294.79%89.95M
153.07%60.15M
71.73%41.39M
59.30%101.64M
51.14%30.99M
23.97%22.79M
70.79%23.77M
Operating profit
-195.89%-164.13M
-160.63%-393.34M
-256.28%-164.74M
-169.62%-98.56M
-118.99%-74.57M
-62.79%-55.47M
-49.68%-150.92M
-57.89%-46.24M
-34.08%-36.56M
-43.45%-34.05M
Net non-operating interest income expense
-41.06%5.8M
-17.62%33.65M
-34.98%7.04M
-32.53%7.76M
-23.67%9.01M
46.49%9.84M
173.55%40.85M
131.20%10.82M
143.23%11.51M
161.40%11.8M
Non-operating interest income
-41.20%5.8M
-17.67%33.7M
-35.13%7.04M
-32.60%7.77M
-23.58%9.03M
46.24%9.86M
172.57%40.94M
130.43%10.84M
143.63%11.53M
159.95%11.82M
Total other finance cost
----
-40.43%56K
--0
-66.67%8K
33.33%24K
-14.29%24K
6.82%94K
-7.69%24K
1,100.00%24K
-43.75%18K
Other net income (expense)
-50.89%55K
4,000.00%41K
-90.83%10K
100.00%4K
112K
1K
109K
2K
Gain on sale of security
----
-50.89%55K
4,000.00%41K
-90.83%10K
100.00%4K
----
--112K
--1K
--109K
--2K
Income before tax
-246.98%-158.33M
-227.05%-359.64M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
Income tax
Net income
-246.98%-158.33M
-227.05%-359.64M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
Net income continuous Operations
-246.98%-158.33M
-227.05%-359.64M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
Minority interest income
Net income attributable to the parent company
-246.98%-158.33M
-227.05%-359.64M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-246.98%-158.33M
-227.05%-359.64M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
Basic earnings per share
-234.15%-1.37
-215.84%-3.19
-331.25%-1.38
-268.18%-0.81
-190.00%-0.58
-57.69%-0.41
-10.99%-1.01
-28.00%-0.32
4.35%-0.22
-5.26%-0.2
Diluted earnings per share
-234.15%-1.37
-215.84%-3.19
-331.25%-1.38
-268.18%-0.81
-190.00%-0.58
-57.69%-0.41
-10.99%-1.01
-28.00%-0.32
4.35%-0.22
-5.26%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 195.89%164.13M160.63%393.34M256.28%164.74M169.62%98.56M118.99%74.57M62.79%55.47M49.68%150.92M57.89%46.24M34.08%36.56M43.45%34.05M
Selling and administrative expenses -0.73%13.98M-1.81%48.39M-26.04%11.28M-37.49%8.61M40.21%14.42M41.20%14.08M33.11%49.28M73.64%15.25M54.97%13.77M4.70%10.29M
-General and administrative expense -0.73%13.98M-1.81%48.39M-26.04%11.28M-37.49%8.61M40.21%14.42M41.20%14.08M33.11%49.28M73.64%15.25M54.97%13.77M4.70%10.29M
Research and development costs 262.76%150.15M239.38%344.96M395.24%153.46M294.79%89.95M153.07%60.15M71.73%41.39M59.30%101.64M51.14%30.99M23.97%22.79M70.79%23.77M
Operating profit -195.89%-164.13M-160.63%-393.34M-256.28%-164.74M-169.62%-98.56M-118.99%-74.57M-62.79%-55.47M-49.68%-150.92M-57.89%-46.24M-34.08%-36.56M-43.45%-34.05M
Net non-operating interest income expense -41.06%5.8M-17.62%33.65M-34.98%7.04M-32.53%7.76M-23.67%9.01M46.49%9.84M173.55%40.85M131.20%10.82M143.23%11.51M161.40%11.8M
Non-operating interest income -41.20%5.8M-17.67%33.7M-35.13%7.04M-32.60%7.77M-23.58%9.03M46.24%9.86M172.57%40.94M130.43%10.84M143.63%11.53M159.95%11.82M
Total other finance cost -----40.43%56K--0-66.67%8K33.33%24K-14.29%24K6.82%94K-7.69%24K1,100.00%24K-43.75%18K
Other net income (expense) -50.89%55K4,000.00%41K-90.83%10K100.00%4K112K1K109K2K
Gain on sale of security -----50.89%55K4,000.00%41K-90.83%10K100.00%4K------112K--1K--109K--2K
Income before tax -246.98%-158.33M-227.05%-359.64M-345.16%-157.66M-264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M
Income tax
Net income -246.98%-158.33M-227.05%-359.64M-345.16%-157.66M-264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M
Net income continuous Operations -246.98%-158.33M-227.05%-359.64M-345.16%-157.66M-264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M
Minority interest income
Net income attributable to the parent company -246.98%-158.33M-227.05%-359.64M-345.16%-157.66M-264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -246.98%-158.33M-227.05%-359.64M-345.16%-157.66M-264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M
Basic earnings per share -234.15%-1.37-215.84%-3.19-331.25%-1.38-268.18%-0.81-190.00%-0.58-57.69%-0.41-10.99%-1.01-28.00%-0.324.35%-0.22-5.26%-0.2
Diluted earnings per share -234.15%-1.37-215.84%-3.19-331.25%-1.38-268.18%-0.81-190.00%-0.58-57.69%-0.41-10.99%-1.01-28.00%-0.324.35%-0.22-5.26%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -